Drug’s antiinflammatory properties may help alleviate pain in patients with OA, reduce risk of myocardial infarction, but toxicity, drug interactions need to be considered
Treatment Options, Guidelines for Managing Gout Discussed at the ACR/ARHP Winter Rheumatology Symposium
Better understanding of goals, effect of gout therapy with nonsteroidal anti-inflammatory drugs, urate lowering medication needed to improve quality of care
Rheumatology Research Foundation to Play Role in Developing New RA, Lupus Treatments
Foundation joins Accelerating Medicines Partnership, led by National Institutes of Health, to fast-track viable potential drug therapies for lupus, rheumatoid arthritis
Research Reveals Clues Into Inflammatory Process of Crystal Arthropathies Note Experts at the 2013 ACR/ARHP Annual Meeting
New studies clarify the roles of monosodium urate crystals in gout, calcium pyrophosphate crystals in osteoarthritis, and identify more effective potential therapies for patients
Do Women Receive Worse Gout Treatment Than Men?
Women with gout are more likely to have contraindications to nonsteroidal antiinflammatory drugs and are less likely to receive urate-lowering drugs than men with the disease. (posted Feb. 5)
Letters: A Word of Caution on Colchicine Study
A rheumatologist warns against generalizing findings of the study reported in “Colchine Effective for Acute Pericarditis” [published online October 31, 2013] to all patients with rheumatic diseases
Colchicine Effective for Acute Pericarditis
Patients with acute pericarditis who are treated with colchicine in combination with a traditional antiinflammatory therapy experience a significantly reduced rate of incessant or recurrent pericarditis. (posted Oct. 31)
New Insights into CPPD
Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease
Large Genome Study Identifies Genetic Risk Factors for Gout
Researchers have identified 28 genome-wide significant urate concentration–associated loci, underscoring the importance of metabolic control in urate production.
Letter: Should We Monitor Asymptomatic Hyperuricemia?
Why have physicians stopped routine screening for hyperuricemia and is there any value to this screening?
- « Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 22
- Next Page »